Eldelumab
Based on 1 Customer Validation
Eldelumab (BMS-936557; MDX-1100) is a fully human IgG1 monoclonal antibody targeting IP-10 (CXCL10). Eldelumab binds and neutralizes IP-10, blocking TNF-α induction, disruption of endothelial junctional complexes, integrin activation, and activated T cell migration. Eldelumab selectively reduces TNF-α release in infected endothelial cells and restores Claudin5, Occludin, ZO-1, and VE-Cadherin expression. Eldelumab can be used for research on hand, foot, and mouth disease (HFMD) and ulcerative colitis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.50%
- CAS 番号: 946414-98-8
- 分子量:146.64 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Isotype
Human IgG1(K214R) kappa
Recommend Isotype Controls
Species Reactivity
Human
|
IP-10 (CXCL10) |
TNF-α |
Claudin5 |
Occludin |
ZO-1 |
VE-Cadherin |
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
- Scratch/Wound-Healing Migration Assay
- RNA extraction experimental
- Cell migration
- Neural Crest/Neuronal Cell Migration Explant Assay
- Research Protocol for Cancer Immunology
- Zigmond Chamber Chemotaxis Assay
- Under-Agarose Cell Migration Assay
- DSS-Induced Colitis
- Transwell/Boyden Chamber Migration Assay
- TNBS-Induced Colitis
- Endothelial Tube Formation Assay
- 3D Collagen/Hydrogel Matrix Migration Assay
- Cell-Exclusion Zone Migration Assay
- Dunn/Insall Chamber Chemotaxis Assay
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Human IP-10/CXCL10 Protein can bind Eldelumab. The EC50 for this effect is 1.68 ng/mL.
化学情報
-
CAS 番号 946414-98-8
-
性状 Liquid
-
分子量 146.64 kDa
-
Color Colorless to light yellow
-
SMILES
[Eldelumab]
-
別名
BMS-936557; MDX-1100
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (268 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Eldelumab
- 946414-98-8
- BMS-936557
- MDX-1100
- BMS936557
- BMS 936557
- MDX1100
- MDX 1100
- MDX-1100
- CXCR
- TNF Receptor
- CXC chemokine receptors
- C-X-C motif chemokine receptors
- Tumor Necrosis Factor Receptor
- TNFR
- CXCL10
- Claudin5
- Occludin
- T-cell migration
- TNF-α
- VE-Cadherin
- ZO-1
- endothelial junctional complex
- hand
- foot and mouth disease
- ulcerative colitis
- Inhibitor
- inhibitor
- inhibit